High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial - Hijazi, Z; Siegbahn, A; Andersson, U (Circulation, 2014)
et al.